Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,963 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community.
Rodríguez-Gómez O, Rodrigo A, Iradier F, Santos-Santos MA, Hundemer H, Ciudin A, Sannemann L, Zwan M, Glaysher B, Wimo A, Bonn J, Johansson G, Rodriguez I, Alegret M, Gove D, Pinó S, Trigueros P, Kivipelto M, Mathews B, Ciudad A, Ferreira D, Bintener C, Gurruchaga M, Westman E, Belger M, Valero S, Maguire P, Krivec D, Kramberger M, Simó R, Garro IP, Visser PJ, Dumas A, Georges J, Jessen F, Winblad B, Shering C, Stewart N, Campo L, Boada M; MOPEAD Consortium. Rodríguez-Gómez O, et al. Among authors: ferreira d. Alzheimers Dement. 2019 Jun;15(6):828-839. doi: 10.1016/j.jalz.2019.02.003. Epub 2019 May 7. Alzheimers Dement. 2019. PMID: 31076376 Free article. Review.
Cognitive decline is mediated by gray matter changes during middle age.
Ferreira D, Molina Y, Machado A, Westman E, Wahlund LO, Nieto A, Correia R, Junqué C, Díaz-Flores L, Barroso J. Ferreira D, et al. Neurobiol Aging. 2014 May;35(5):1086-94. doi: 10.1016/j.neurobiolaging.2013.10.095. Epub 2013 Oct 29. Neurobiol Aging. 2014. PMID: 24239436
Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis.
Ferreira D, Rivero-Santana A, Perestelo-Pérez L, Westman E, Wahlund LO, Sarría A, Serrano-Aguilar P. Ferreira D, et al. Front Aging Neurosci. 2014 Oct 16;6:287. doi: 10.3389/fnagi.2014.00287. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25360114 Free PMC article. Review.
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, Nordberg A, Wahlberg L, Darreh-Shori T, Eriksdotter M. Karami A, et al. Among authors: ferreira d. Alzheimers Dement. 2015 Nov;11(11):1316-28. doi: 10.1016/j.jalz.2014.11.008. Epub 2015 Feb 9. Alzheimers Dement. 2015. PMID: 25676388
The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects.
Falahati F, Ferreira D, Soininen H, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Lovestone S, Eriksdotter M, Wahlund LO, Simmons A, Westman E; AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative. Falahati F, et al. Among authors: ferreira d. Brain Topogr. 2016 Mar;29(2):296-307. doi: 10.1007/s10548-015-0455-1. Epub 2015 Oct 6. Brain Topogr. 2016. PMID: 26440606 Free PMC article.
Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition.
Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative*. Ferreira D, et al. Eur Radiol. 2016 Aug;26(8):2597-610. doi: 10.1007/s00330-015-4101-9. Epub 2015 Nov 11. Eur Radiol. 2016. PMID: 26560730
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.
Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, Winblad B, Seiger Å, Wahlberg L, Almqvist P. Eyjolfsdottir H, et al. Among authors: ferreira d. Alzheimers Res Ther. 2016 Jul 7;8(1):30. doi: 10.1186/s13195-016-0195-9. Alzheimers Res Ther. 2016. PMID: 27389402 Free PMC article. Clinical Trial.
1,963 results